We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,939
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$2.84T
| $13B | 5.25% |
55,685,323
-1,114,360
| -2% | -$294M |
|
2
Apple
AAPL
$4.89T
| $11.4B | 4.63% |
82,710,223
-226,754
| -0.3% | -$35.6M |
|
3
Amazon
AMZN
$2.5T
| $6.99B | 2.83% |
61,852,731
+742,720
| +1% | +$93.9M |
|
4
Tesla
TSLA
$1.24T
| $4.12B | 1.67% |
15,529,056
-102,852
| -0.7% | -$28.7M |
|
|
5
UnitedHealth
UNH
$382B
| $3.67B | 1.49% |
7,276,059
+367,153
| +5% | +$193M |
|
|
6
Alphabet (Google) Class C
GOOG
$3.9T
| $3.38B | 1.37% |
35,166,262
-1,574,678
| -4% | -$176M |
|
|
7
Alnylam Pharmaceuticals
ALNY
$36.3B
| $3.32B | 1.35% |
16,593,268
+16,296,223
| +5,486% | +$3.11B |
|
|
8
Alphabet (Google) Class A
GOOGL
$3.91T
| $3.22B | 1.3% |
33,615,585
-3,093,155
| -8% | -$343M |
|
9
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $2.56B | 1.04% |
24,989,576
| – | – |
|
10
Mastercard
MA
$477B
| $2.55B | 1.03% |
8,972,049
-253,936
| -3% | -$84.2M |
|
11
Visa
V
$677B
| $2.48B | 1% |
13,946,072
-306,372
| -2% | -$62.3M |
|
12
Nuveen Growth Opportunities ETF
NUGO
$2.41B
| $2.18B | 0.88% |
127,727,110
-738,031
| -0.6% | -$14.1M |
|
13
Broadcom
AVGO
$1.82T
| $1.98B | 0.8% |
44,525,430
+1,880,780
| +4% | +$96.1M |
|
14
Johnson & Johnson
JNJ
$635B
| $1.91B | 0.78% |
11,714,530
-661,110
| -5% | -$112M |
|
15
Costco
COST
$415B
| $1.88B | 0.76% |
3,976,109
-117,639
| -3% | -$61.2M |
|
16
AbbVie
ABBV
$458B
| $1.82B | 0.74% |
13,565,946
-1,124,828
| -8% | -$161M |
|
17
NVIDIA
NVDA
$5.01T
| $1.79B | 0.72% |
147,308,460
-8,748,510
| -6% | -$138M |
|
18
PepsiCo
PEP
$186B
| $1.77B | 0.72% |
10,848,950
+816,417
| +8% | +$141M |
|
19
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.72B | 0.7% |
6,438,577
-106,598
| -2% | -$30.3M |
|
20
Home Depot
HD
$332B
| $1.69B | 0.68% |
6,111,885
+430,696
| +8% | +$127M |
|
21
Eli Lilly
LLY
$1.07T
| $1.66B | 0.67% |
5,134,198
-44,141
| -0.9% | -$14M |
|
22
JPMorgan Chase
JPM
$939B
| $1.63B | 0.66% |
15,606,783
+102,242
| +0.7% | +$11.7M |
|
|
23
Meta Platforms (Facebook)
META
$1.51T
| $1.57B | 0.64% |
11,581,572
-1,847,922
| -14% | -$300M |
|
24
Procter & Gamble
PG
$343B
| $1.55B | 0.63% |
12,282,824
-598,281
| -5% | -$85M |
|
25
Elevance Health
ELV
$81.9B
| $1.52B | 0.62% |
3,346,064
+166,290
| +5% | +$79.6M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.